These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 11230991

  • 1. Pharmacological characterisation of human 5-HT2 receptor subtypes.
    Jerman JC, Brough SJ, Gager T, Wood M, Coldwell MC, Smart D, Middlemiss DN.
    Eur J Pharmacol; 2001 Feb 23; 414(1):23-30. PubMed ID: 11230991
    [Abstract] [Full Text] [Related]

  • 2. Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells.
    Porter RH, Benwell KR, Lamb H, Malcolm CS, Allen NH, Revell DF, Adams DR, Sheardown MJ.
    Br J Pharmacol; 1999 Sep 23; 128(1):13-20. PubMed ID: 10498829
    [Abstract] [Full Text] [Related]

  • 3. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
    Song J, Hanniford D, Doucette C, Graham E, Poole MF, Ting A, Sherf B, Harrington J, Brunden K, Stricker-Krongrad A.
    Assay Drug Dev Technol; 2005 Dec 23; 3(6):649-59. PubMed ID: 16438660
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
    Knight AR, Misra A, Quirk K, Benwell K, Revell D, Kennett G, Bickerdike M.
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug 23; 370(2):114-23. PubMed ID: 15322733
    [Abstract] [Full Text] [Related]

  • 5. Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, -HT(2B) and 5-HT2C receptors.
    Nelson DL, Lucaites VL, Wainscott DB, Glennon RA.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jan 23; 359(1):1-6. PubMed ID: 9933142
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Identification of the binding sites and selectivity of sarpogrelate, a novel 5-HT2 antagonist, to human 5-HT2A, 5-HT2B and 5-HT2C receptor subtypes by molecular modeling.
    Rashid M, Manivet P, Nishio H, Pratuangdejkul J, Rajab M, Ishiguro M, Launay JM, Nagatomo T.
    Life Sci; 2003 May 30; 73(2):193-207. PubMed ID: 12738034
    [Abstract] [Full Text] [Related]

  • 12. High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: evidence favoring the ternary complex and two-state models of agonist action.
    Fitzgerald LW, Conklin DS, Krause CM, Marshall AP, Patterson JP, Tran DP, Iyer G, Kostich WA, Largent BL, Hartig PR.
    J Neurochem; 1999 May 30; 72(5):2127-34. PubMed ID: 10217294
    [Abstract] [Full Text] [Related]

  • 13. Ejaculatory response induced by a 5-HT2 receptor agonist m-CPP in rats: differential roles of 5-HT2 receptor subtypes.
    Yonezawa A, Yoshizumi M, Ebiko M, Ise SN, Watanabe C, Mizoguchi H, Kimura Y, Sakurada S.
    Pharmacol Biochem Behav; 2008 Feb 30; 88(4):367-73. PubMed ID: 17936345
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 1-[4-(3-Phenylalkyl)phenyl]-2-aminopropanes as 5-HT(2A) partial agonists.
    Dowd CS, Herrick-Davis K, Egan C, DuPre A, Smith C, Teitler M, Glennon RA.
    J Med Chem; 2000 Aug 10; 43(16):3074-84. PubMed ID: 10956215
    [Abstract] [Full Text] [Related]

  • 19. Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus.
    Berg KA, Maayani S, Goldfarb J, Scaramellini C, Leff P, Clarke WP.
    Mol Pharmacol; 1998 Jul 10; 54(1):94-104. PubMed ID: 9658194
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.